Dan Curtis joins Amylon Therapeutics as Chief Development Officer

Dan Curtis joins Amylon Therapeutics as Chief Development Officer Cambridge, Massachusetts, 26 June 2018 – Amylon Therapeutics, a biotechnology company using an ultragenetics approach towards neurological disorders, announces the appointment

Share
Amylon Therapeutics and Alcyone Lifesciences enter into partnership

Amylon Therapeutics and Alcyone Lifesciences enter into partnership on drug-device combo to treat HCHWA-D Amylon Therapeutics and Alcyone Lifesciences enter into partnership on drug-device combo to treat HCHWA-D Cambridge, Massachusetts,

Share
Dr. Bo Jesper Hansen joins supervisory board Amylon Therapeutics

Dr. Bo Jesper Hansen joins supervisory board Amylon Therapeutics LEIDEN, The Netherlands, February 21st 2018, Amylon Therapeutics, a biotechnology company using an ultra-genetic approach towards neurological disorders, announces the appointment

Share
Amylon Therapeutics Targeting central NSD Wins SSC at BIO-EU® Berlin   

Amylon Therapeutics Targeting central Nervous System Disorders  Wins Startup Slam Competition at BIO-Europe® Berlin   Eight short-listed life sciences startups pitched to expert panel of judges at fourth Startup Slam

Share
ProQR spins out Amylon Therapeutics

ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics Key updates ProQR spins out CNS-focused company, Amylon Therapeutics, with seed funding from a

Share
Amylon Therapeutics rondt eerste fase startkapitaal af

Amylon Therapeutics rondt eerste fase startkapitaal af, Focus op aandoeningen van het centraal zenuwstelsel. Belangrijkste updates Amylon Therapeutics B.V. is een spin-off bedrijf van ProQR Therapeutics N.V., een aan NASDAQ

Share
Amylon Therapeutics announces seed investment round

Amylon Therapeutics announces seed investment round, focus on CNS disorders   Key updates Amylon Therapeutics B.V. is a spin-off company from ProQR Therapeutics N.V., a NASDAQ listed biopharmaceutical company based

Share